title: Profound thrombocytopenia in previously treated patients with recurrent ovarian carcinoma receiving topotecan.
authors.forename: B
authors.initials: B
authors.lastname: Abendstein
authors.forename: P J
authors.initials: PJ
authors.lastname: Klingler
authors.forename: B U
authors.initials: BU
authors.lastname: Sevin
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects; D001323:Autoantibodies / Q000097:blood*; D002277:Carcinoma / Q000188:drug therapy / Q000276:immunology*; D005260:Female; D006801:Humans; D007122:Immunoelectrophoresis; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000276:immunology*; D009474:Neurons / Q000276:immunology*; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000276:immunology*; D013921:Thrombocytopenia / Q000139:chemically induced / Q000276:immunology*; D019772:Topotecan / Q000009:adverse effects
chemical_list: D000970:Antineoplastic Agents; D001323:Autoantibodies; D019772:Topotecan